Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus

J Pediatr Endocrinol Metab. 2008 Dec;21(12):1163-8. doi: 10.1515/jpem.2008.21.12.1163.


Aim: To appraise the economic burden for families of patients with type 1 diabetes mellitus (DM1) at the Instituto Nacional de Pediatria in Mexico City.

Patients and methods: DM1 family direct costs were obtained from a standardized economic survey in 59 children with no chronic severe complications such as kidney failure in 2002-3.

Results: Mean family annual direct cost of treatment and monitoring was US $1689.87 which includes government funding given to both outpatients and inpatients. Despite this, DM1 out-of-pocket cost for families is very high compared to the minimum official wage of approximately $4.00 dollar/day versus $4.06 cost DM1/day. No correlation between parents' age, education or socio-economic level and direct cost was statistically significant.

Conclusions: The highest economic burden was due to self-monitoring of blood glucose (SMBG) 53.0% and insulin 14.8%. The costs were higher in children with poor metabolic control who performed SMBG less often.

MeSH terms

  • Adolescent
  • Blood Glucose / metabolism
  • Blood Glucose Self-Monitoring / economics
  • Child
  • Cost of Illness*
  • Data Collection
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / economics*
  • Diabetes Mellitus, Type 1 / metabolism
  • Family*
  • Female
  • Health Care Costs / statistics & numerical data*
  • Humans
  • Insulin / blood
  • Male
  • Mexico


  • Blood Glucose
  • Insulin